Changes in therapy, primarily intensification, for childhood leukemias have
significantly improved cure rates during the past 30 years. The increasing
number of survivors has led to a heightened appreciation of the late compl
ications of treatment caused by both radiation and chemotherapy, Important
late effects include decreased growth, poor school performance, altered car
diac function, infertility, and second malignant neoplasms. The long term o
utcome of children and adolescents suffering from the most recently recogni
zed acute complication of treatment, avascular necrosis of weightbearing bo
nes, is still not known. These, and all patients treated on clinical trials
, should be followed throughout their lives, Many of the complications of t
reatment are often not realized until years after the completion of therapy
; some have been found to be related to dose intensity, emphasizing the imp
ortance of clinical trials that examine reduction of therapy for diseases w
ith excellent cure rates, A successful example of this strategy is the elim
ination or reduction of radiation dose for the prevention of central nervou
s system acute lymphocytic leukemia. This has resulted in fewer long term c
entral nervous system complications without a decrease in survival rates, A
s knowledge of late effects increases, design of future trials will need to
focus on striking a balance between cure and long term toxicity, (C) 2000
Lippincott Williams & Wilkins, Inc.